latest update:
[RxAtlas]

drug summary · 4 NDC codes

Cobenfy 125 mg/1; 30 mg/1

xanomeline and trospium chloride

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 23138NDC codes 4application NDA216158RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namexanomeline and trospium chloride
active ingredientsTROSPIUM CHLORIDE, XANOMELINE
dosage formCAPSULE, COATED PELLETS
routeORAL
strength125 mg/1; 30 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA216158
ATC codenot reported
RxCUInot reported
manufacturerE.R. Squibb & Sons, L.L.C.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classCholinergic Muscarinic Agonist [EPC]; Cholinergic Muscarinic Agonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

NDC codes

4 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00003012514—
00003012560—
00003012598—
0003-0125—

Other xanomeline and trospium chloride products

2 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.